Tokyo, Japan – 7 December 2007: Sosei Group Corporation (“Sosei”, TSE Mothers Index: 4565), a biopharmaceutical company, today announces that Sosei has resolved at the Board of Directors meeting held on 7 December 2007 to raise up to ¥5.0bn of new funds through the issuance of Stock Acquisition Rights (“SARs”) by way of third-party allotment to Nomura Securities Co., Ltd. (“Nomura”).
The key terms of the SARs are summarised below.